Page last updated: 2024-08-21

adamantane and Peripheral Vascular Diseases

adamantane has been researched along with Peripheral Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatt, DL; Bonaca, MP; Braunwald, E; Gutierrez, JA; Hirshberg, B; Im, K; Mosenzon, O; Raz, I; Scirica, BM; Steg, PG1
Jago, C1

Trials

1 trial(s) available for adamantane and Peripheral Vascular Diseases

ArticleYear
Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).
    The American journal of cardiology, 2019, 01-01, Volume: 123, Issue:1

    Topics: Adamantane; Aged; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Risk Factors; Treatment Outcome

2019

Other Studies

1 other study(ies) available for adamantane and Peripheral Vascular Diseases

ArticleYear
American Diabetes Association--66th scientific sessions. 9-13 June 2006, Washington, DC, USA.
    IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:8

    Topics: Adamantane; Clinical Trials as Topic; Glucagon-Like Peptide 1; Humans; Liraglutide; Nitriles; Peripheral Vascular Diseases; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Triazoles; Vildagliptin

2006